N
Nazia Rashid
Researcher at ACADIA Pharmaceuticals Inc.
Publications - 8
Citations - 32
Nazia Rashid is an academic researcher from ACADIA Pharmaceuticals Inc.. The author has contributed to research in topics: Dementia & Dementia with Lewy bodies. The author has an hindex of 2, co-authored 8 publications receiving 7 citations. Previous affiliations of Nazia Rashid include Keck Graduate Institute of Applied Life Sciences.
Papers
More filters
Journal ArticleDOI
Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome.
Isaac Melamed,Roger H. Kobayashi,Maeve O’Connor,Ai Lan Kobayashi,Andrew Schechterman,Melinda Heffron,Sharon Canterberry,Holly Miranda,Nazia Rashid +8 more
TL;DR: In this article, a clinical diagnosis in children who have an acute manifestation of varied neuropsychiatric symptoms, including obsessive compulsive disorder (OCD), is presented. But, the diagnosis is not specific to any specific patient.
Journal ArticleDOI
Association of Dementia-related Psychosis with Long-term Care Use and Death.
James B. Wetmore,Yi Peng,Heng Yan,Suying Li,Muna Irfan,Andrew Shim,Nicholas S. Roetker,Victor Abler,Nazia Rashid,Nazia Rashid,David T. Gilbertson +10 more
TL;DR: In this article, the association of dementia-related psychosis (DRP) with death and use of long-term care (LTC) was investigated in a large-scale study.
Journal ArticleDOI
Burden of illness among patients with dementia-related psychosis.
TL;DR: Abler et al. as discussed by the authors compared real-world clinical events, health care resource utilization (HCRU), and health care costs among matched cohorts of DRP versus dementia-only patients.
Journal ArticleDOI
Real-World Medication Treatment Patterns for Long-Term Care Residents with Dementia-Related Psychosis.
TL;DR: In this paper, the authors evaluated treatment patterns and factors associated with medication treatment changes in residents with dementia-related psychosis in a long-term care (LTC) setting, and found that patients with dementia related psychosis were more likely to experience suicidal ideation.
Journal ArticleDOI
Treatment Patterns With Antipsychotics in Long-Term Care Patients With Parkinson’s Disease Psychosis:
TL;DR: In this paper, treatment change patterns in Parkinson's disease psychosis (PDP) residents receiving antipsychotic (AP) therapies in U.S. long-term care (LTC) facilities were assessed.